2022
Relationship Between Glucose Time in Range in Diabetic and Non-Diabetic Patients and Mortality in Critically Ill Patients
Ammar MA, Ammar AA, Wee T, Deshpande R, Band M, Akhtar S. Relationship Between Glucose Time in Range in Diabetic and Non-Diabetic Patients and Mortality in Critically Ill Patients. Journal Of Intensive Care Medicine 2022, 37: 1625-1633. PMID: 35491687, DOI: 10.1177/08850666221098383.Peer-Reviewed Original ResearchConceptsNon-diabetic patientsBlood glucose rangeDiabetic patientsIll patientsGlucose rangeTIR 70Hospital mortalityMortality rateHospital mortality rateNon-diabetic cohortLower mortality rateAdult patientsCohort studyMortality benefitSingle centerGlucose timePercentage of timeHigh incidencePatientsMortalityDlLtDiabeticsICUHyperglycemia
2021
Patients with insulin-dependent diabetes are at greater risk for perioperative adverse outcomes following total hip arthroplasty
Webb ML, Justen MA, Kerbel YE, Scanlon CM, Nelson CL, Grauer JN. Patients with insulin-dependent diabetes are at greater risk for perioperative adverse outcomes following total hip arthroplasty. Hip International 2021, 32: 730-736. PMID: 33566714, DOI: 10.1177/1120700020988834.Peer-Reviewed Original ResearchConceptsTotal hip arthroplastyPerioperative adverse outcomesAdverse outcomesDiabetes mellitusHip arthroplastyNational Surgical Quality Improvement Program databaseQuality Improvement Program databasePrimary total hip arthroplastyAdditional adverse outcomesImprovement Program databaseInsulin-dependent diabeticsPreoperative risk stratificationInsulin-dependent diabetesQuality improvement initiativesInsulin useDependent diabeticsRisk stratificationProgram databasePatientsMultivariate analysisGreater riskImprovement initiativesDiabeticsOutcomesDiabetes
2018
Physical training reverses changes in hepatic mitochondrial diameter of Alloxan-induced diabetic rats
Kuga G, Gaspar R, Muñoz V, Nakandakari S, Breda L, Sandoval B, Caetano F, de Almeida Leme J, Pauli J, Gomes R. Physical training reverses changes in hepatic mitochondrial diameter of Alloxan-induced diabetic rats. Einstein (São Paulo) 2018, 16: eao4353. PMID: 30088548, PMCID: PMC6110382, DOI: 10.1590/s1679-45082018ao4353.Peer-Reviewed Original ResearchConceptsDiabetic ratsBody weightDiabetic groupSedentary diabeticDiabetic animalsPhysical trainingSedentary diabetic animalsPhysical training protocolMitochondrial diameterDiabetes mellitusAlloxan administrationBlood insulinExercise protocolSerum glucoseSedentary controlsWistar ratsHepatic metabolismReverses changesLiver glycogenHepatic glycogenDiabeticsRatsMeasurements of glycogenLiver samplesTraining protocol
2016
CRT-200.54 Evaluation of 2-year Clinical Outcomes From Post-market Trials With Everolimus-eluting Cobalt Chromium Stents in Diabetics
Ng V, Seth A, Alkhalil I, Grube E, Morice M, Mao V, Deible R, Sudhir K, Lansky A. CRT-200.54 Evaluation of 2-year Clinical Outcomes From Post-market Trials With Everolimus-eluting Cobalt Chromium Stents in Diabetics. JACC Cardiovascular Interventions 2016, 9: s20. DOI: 10.1016/j.jcin.2015.12.086.Peer-Reviewed Original Research
2012
IMPACT OF POINT-OF-CARE PLATELET FUNCTION TESTING AMONG DIABETIC AND NON-DIABETIC PATIENTS UNDERGOING PCI WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDY
Kirtane A, Stuckey T, Parise H, Witzenbichler B, Weisz G, Rinaldi M, Neumann F, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Mazzaferri E, Cristea E, Mehran R, Stone G. IMPACT OF POINT-OF-CARE PLATELET FUNCTION TESTING AMONG DIABETIC AND NON-DIABETIC PATIENTS UNDERGOING PCI WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDY. Journal Of The American College Of Cardiology 2012, 59: e268. DOI: 10.1016/s0735-1097(12)60269-1.Peer-Reviewed Original Research
2008
Factors Associated With Longer Time From Symptom Onset to Hospital Presentation for Patients With ST-Elevation Myocardial Infarction
Ting HH, Bradley EH, Wang Y, Lichtman JH, Nallamothu BK, Sullivan MD, Gersh BJ, Roger VL, Curtis JP, Krumholz HM. Factors Associated With Longer Time From Symptom Onset to Hospital Presentation for Patients With ST-Elevation Myocardial Infarction. JAMA Internal Medicine 2008, 168: 959-968. PMID: 18474760, PMCID: PMC4858313, DOI: 10.1001/archinte.168.9.959.Peer-Reviewed Original ResearchConceptsST-elevation myocardial infarctionMyocardial infarctionHospital presentationSymptom onsetPatient subgroupsRisk factorsOnset of symptomsQuality of careRace/ethnicityNational registryPatient responsivenessInfarctionPatientsReference groupSubgroupsWomenMenCareOnsetMinutesPresentationYearsHoursGeometric meanDiabetics
1998
Protein Glycation and Diabetic Vascular Disease
Bucala R, Rahbar S. Protein Glycation and Diabetic Vascular Disease. Endocrine Updates 1998, 1: 159-180. DOI: 10.1007/978-1-4615-5569-8_9.Peer-Reviewed Original ResearchVascular diseaseNon-insulin dependent diabeticsAtherosclerotic vascular diseaseEnd-organ complicationsDiabetic vascular diseaseDiabetic glucose controlOverall morbidityDependent diabeticsGlucose controlPersistent hyperglycemiaDiabetic complicationsComplicationsUnderlying causeProtein glycationDiseaseDiabeticsMorbidityHyperglycemiaRetinopathyPatientsMortality
1997
Circulating Thrombomodulin Levels and Clinical Correlates in Pregnant Diabetics
Magriples U, Hsu C, Chan D, Nickless N, Copel J. Circulating Thrombomodulin Levels and Clinical Correlates in Pregnant Diabetics. American Journal Of Perinatology 1997, 14: 605-608. PMID: 9605246, DOI: 10.1055/s-2008-1040762.Peer-Reviewed Original ResearchConceptsDuration of diabetesPregnant diabeticsClinical correlatesGroup 1Prospective cohort studyInsulin-dependent diabetesWeeks of gestationGestational diabetesCohort studyDiabetic pregnanciesSerum creatinineRenal diseaseThrombomodulin levelsEndothelial damageWhite classificationUnderwent determinationTM levelsDiabetesHbA1cDiabeticsThrombomodulinShort-term controlSignificant differencesDurationCorrelates
1996
Effect of experimental diabetes on rat prostate endothelin receptors
Saito M, Nishi K, Foster H, Weiss R, Latifpour J. Effect of experimental diabetes on rat prostate endothelin receptors. European Journal Of Pharmacology 1996, 310: 197-200. PMID: 8884217, DOI: 10.1016/0014-2999(96)00422-0.Peer-Reviewed Original ResearchStrategies for Reducing the Frequency of Preeclampsia in Pregnancies with Insulin-Dependent Diabetes Mellitus
Hsu C, Tan H, Hong S, Nickless N, Copel J. Strategies for Reducing the Frequency of Preeclampsia in Pregnancies with Insulin-Dependent Diabetes Mellitus. American Journal Of Perinatology 1996, 13: 265-268. PMID: 8863944, DOI: 10.1055/s-2007-994340.Peer-Reviewed Original ResearchConceptsFrequency of preeclampsiaIncidence of preeclampsiaGlycemic controlIDDM pregnanciesExact testPregnant insulin-dependent diabeticsYale-New Haven HospitalInsulin-dependent diabeticsOccurrence of preeclampsiaComplete medical recordsFisher's exact testChi-square testInsulin-DependentMedical recordsLower incidencePreeclampsiaGroup 2Group 1PregnancyGroup 3Group 4IncidenceEclampsiaMellitusDiabeticsInhibition of phospholipase D and superoxide generation by glucose in diabetic neutrophils
Ortmeyer J, Mohsenin V. Inhibition of phospholipase D and superoxide generation by glucose in diabetic neutrophils. Life Sciences 1996, 59: 255-262. PMID: 8699936, DOI: 10.1016/0024-3205(96)00284-6.Peer-Reviewed Original ResearchConceptsDiabetic neutrophilsSuperoxide generationInsulin-dependent diabeticsGlucose concentrationNormal glucose concentrationN-formyl-MetNeutrophil dysfunctionPhospholipase DHigh glucose concentrationsImpaired activationDiabeticsNeutrophilsLeu-PheMembrane phosphatidylcholineActivationDiabetesDysfunctionInfectionFMLPPhosphatidic acidResponse
1993
Baylor update: outcome analysis in liver transplantation.
Levy M, Goldstein R, Husberg B, Gonwa T, Backman L, Abouljoud M, Mulligan D, Klintmalm G. Baylor update: outcome analysis in liver transplantation. Clinical Transplants 1993, 161-73. PMID: 7918148.Peer-Reviewed Original ResearchConceptsLiver transplantationLong-term renal functionHepatitis B antigenemiaLate graft lossKaplan-Meier curvesGraft lossYear posttransplantLiver transplantElderly patientsRenal functionClinical correlatesOutcome analysisWhole bloodDisappointing resultsPlasma assaysPatientsTransplantationCurrent protocolsLife dataAntigenemiaPosttransplantDiabeticsCholangiocarcinomaTransplantBlood
1992
Hemoglobin-AGE: A Circulating Marker of Advanced Glycosylation
Makita Z, Vlassara H, Rayfield E, Cartwright K, Friedman E, Rodby R, Cerami A, Bucala R. Hemoglobin-AGE: A Circulating Marker of Advanced Glycosylation. Science 1992, 258: 651-653. PMID: 1411574, DOI: 10.1126/science.1411574.Peer-Reviewed Original ResearchConceptsAdvanced glycosylation end productsAdvanced glycosylationAGE-modified formAGE-specific antibodiesComplications of agingDiabetes-induced hyperglycemiaAge-related complicationsGlycosylation end productsCirculating MarkersDiabetic patientsRenal diseaseGlucose-derived Amadori productsNormal individualsComplicationsPatientsTissue modificationsTissue proteinsHemoglobinAmadori productsEnd productsPercentDiabeticsHyperglycemiaAtherosclerosisDiabetesSterile Needles: Human Immunodeficiency Virus in Diabetic Intravenous Drug Users-Reply
Nelson K, Vlahov D, Anthony J, Solomon L. Sterile Needles: Human Immunodeficiency Virus in Diabetic Intravenous Drug Users-Reply. JAMA 1992, 267: 1340-1341. DOI: 10.1001/jama.1992.03480100046022.Peer-Reviewed Original ResearchDrug injection equipmentHIV infectionHuman immunodeficiency virusInjection equipmentSafe injection practicesDrug injection paraphernaliaImmunodeficiency virusInjection paraphernaliaLow prevalenceInjection practicesDrug usersDiabeticsIVDUsLower ratesInfectionParaphernalia lawsSterile needleBehavioral strategiesPrevalence
1990
Respiratory burst in alveolar macrophages of diabetic rats
Mohsenin V, Latifpour J. Respiratory burst in alveolar macrophages of diabetic rats. Journal Of Applied Physiology 1990, 68: 2384-2390. PMID: 2166735, DOI: 10.1152/jappl.1990.68.6.2384.Peer-Reviewed Original ResearchConceptsPeripheral blood monocytesPhorbol myristate acetateAlveolar macrophagesBlood monocytesInduction of diabetesPMA stimulationEnzyme cycling methodDismutase-inhibitable cytochrome c reductionSuperoxide dismutase-inhibitable cytochrome c reductionNeutrophil O2Diabetes mellitusDiabetic ratsRats 8Basal conditionsDiabeticsAnion generationMacrophagesMyristate acetateMonocytesSignificant differencesDiabetesStimulationCytochrome c reductionRatsRespiratorySonographic Assessment of Growth of the Fetal Head in Diabetic Pregnancies Compared with Normal Gestations
Reece E, Winn H, Smikle C, Holford T, Nelson-Robinson L, DeGennaro N, Hobbins J. Sonographic Assessment of Growth of the Fetal Head in Diabetic Pregnancies Compared with Normal Gestations. American Journal Of Perinatology 1990, 7: 18-22. PMID: 2403791, DOI: 10.1055/s-2007-999437.Peer-Reviewed Original ResearchConceptsBiparietal diameterFetal biparietal diameterGlycemic controlBPD growthFetal headInsulin-dependent diabetic patientsLongitudinal ultrasound studyPresence of euglycemiaWhite classes BGood glycemic controlDiabetic groupObstetric complicationsDiabetic pregnanciesDiabetic patientsFirst trimesterSecond trimesterSonographic assessmentControl fetusesNormal gestationSignificant statistical differenceUltrasound studyControl groupVelocity of growthDiabeticsPregnancy
1986
Implicit models of illness
Turk D, Rudy T, Salovey P. Implicit models of illness. Journal Of Behavioral Medicine 1986, 9: 453-474. PMID: 3795264, DOI: 10.1007/bf00845133.Peer-Reviewed Original ResearchConceptsPhysical health statusDifferent diseasesGroups of subjectsIllness QuestionnaireIllness modelSample of subjectsHealth cognitionsIllnessIllness schemataDiseasePresent studyExploratory factor analysisSame populationSubjectsFactor analysisDiabeticsInitial investigationOccupational rolesNursesConfirmatory factor analysisElastic Fiber and Microvascular Abnormalities in Aging Skin
Braverman I. Elastic Fiber and Microvascular Abnormalities in Aging Skin. Dermatologic Clinics 1986, 4: 391-405. PMID: 3521985, DOI: 10.1016/s0733-8635(18)30802-7.Peer-Reviewed Original ResearchConceptsMicrovascular abnormalitiesSpecific clinical featuresElastic fiber abnormalitiesDiabetic patientsJuvenile diabeticsClinical featuresVeil cellsDiabetic skinFiber abnormalitiesMajor manifestationsIdentical abnormalitiesCutaneous agingAbnormalitiesCutaneous laxitySkinElastic fibersFunctional stateElastic fiber networkWall alterationsAlterationsAging processDiabeticsLikely correlatePatientsAtrophyA Study of the Veil Cells Around Normal, Diabetic, and Aged Cutaneous Microvessels
Braverman I, Sibley J, Keh-Yen A. A Study of the Veil Cells Around Normal, Diabetic, and Aged Cutaneous Microvessels. Journal Of Investigative Dermatology 1986, 86: 57-62. PMID: 3745935, DOI: 10.1111/1523-1747.ep12283816.Peer-Reviewed Original Research
1984
Treatment of Insulin Reactions in Diabetics
Brodows R, Williams C, Amatruda J. Treatment of Insulin Reactions in Diabetics. JAMA 1984, 252: 3378-3381. PMID: 6389915, DOI: 10.1001/jama.1984.03350240024032.Peer-Reviewed Original ResearchConceptsGlycemic responsePlasma free insulin concentrationInsulin-dependent diabeticsFree insulin concentrationsMicroU/mLGlucose clamp techniquePlasma glucose levelsRebound hyperglycemiaSevere hypoglycemiaOutpatient settingSpontaneous episodesInsulin concentrationsInsulin reactionGlucose levelsClamp techniqueHypoglycemiaIngested carbohydrateD-glucoseDiabeticsOrange juiceTreatmentImportant determinantCommon sourceHyperglycemiaPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply